Bank of New York Mellon’s Genocea Biosciences, Inc. GNCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,305
Closed -$20K 4794
2022
Q1
$20K Hold
16,305
﹤0.01% 4614
2021
Q4
$19K Hold
16,305
﹤0.01% 4589
2021
Q3
$31K Hold
16,305
﹤0.01% 4477
2021
Q2
$38K Sell
16,305
-2,535
-13% -$5.91K ﹤0.01% 4352
2021
Q1
$51K Sell
18,840
-1,426
-7% -$3.86K ﹤0.01% 4254
2020
Q4
$49K Hold
20,266
﹤0.01% 4148
2020
Q3
$46K Hold
20,266
﹤0.01% 4027
2020
Q2
$47K Hold
20,266
﹤0.01% 3992
2020
Q1
$35K Buy
+20,266
New +$35K ﹤0.01% 4007
2019
Q3
Sell
-17,054
Closed -$67K 4304
2019
Q2
$67K Buy
17,054
+14,412
+545% +$56.6K ﹤0.01% 4083
2019
Q1
$12K Sell
2,642
-80
-3% -$363 ﹤0.01% 4180
2018
Q4
$6K Hold
2,722
﹤0.01% 4207
2018
Q3
$17K Hold
2,722
﹤0.01% 4207
2018
Q2
$19K Sell
2,722
-21,674
-89% -$151K ﹤0.01% 4166
2018
Q1
$205K Buy
24,396
+13,114
+116% +$110K ﹤0.01% 3914
2017
Q4
$105K Buy
11,282
+576
+5% +$5.36K ﹤0.01% 4073
2017
Q3
$125K Buy
10,706
+191
+2% +$2.23K ﹤0.01% 3970
2017
Q2
$439K Buy
10,515
+9,001
+595% +$376K ﹤0.01% 3656
2017
Q1
$74K Hold
1,514
﹤0.01% 4080
2016
Q4
$50K Sell
1,514
-160
-10% -$5.28K ﹤0.01% 4129
2016
Q3
$69K Sell
1,674
-1,979
-54% -$81.6K ﹤0.01% 4089
2016
Q2
$120K Sell
3,653
-4,890
-57% -$161K ﹤0.01% 4016
2016
Q1
$529K Sell
8,543
-1,527
-15% -$94.6K ﹤0.01% 3415
2015
Q4
$425K Buy
10,070
+930
+10% +$39.3K ﹤0.01% 3585
2015
Q3
$500K Buy
9,140
+783
+9% +$42.8K ﹤0.01% 3552
2015
Q2
$918K Buy
8,357
+5,510
+194% +$605K ﹤0.01% 3389
2015
Q1
$270K Buy
2,847
+1,185
+71% +$112K ﹤0.01% 3816
2014
Q4
$93K Sell
1,662
-35
-2% -$1.96K ﹤0.01% 4048
2014
Q3
$123K Hold
1,697
﹤0.01% 3990
2014
Q2
$255K Buy
+1,697
New +$255K ﹤0.01% 3781